EU Evaluation Of FDA District Offices Under MRA To Begin By Feb. 2001
This article was originally published in The Tan Sheet
Executive Summary
FDA expects European regulators to begin assessing agency district offices in the next six to eight months, Office of Regulatory Affairs Regional Director Deborah Ralston told a June 5 Food & Drug Law Institute meeting in Washington, D.C.
You may also be interested in...
International Harmonization Should Focus On Post-Marketing Activities - HRG
International harmonization efforts should include an emphasis on post-marketing activities, Public Citizen's Health Research Group Deputy Director Peter Lurie, MD, commented at an FDA public meeting on the future of the International Conference on Harmonization May 16.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands